Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In Treatment Of Melasma

• Status: Suspended
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Female

Summary

The objective of this study is evaluating the clinical activity of the association (tretinoin + arbutin + triamcinolone) in the treatment of epidermal melasma.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Azidus Brasil
• Treatments: Tretinoin; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• Women adults aged more than 18 years;

• Patients suffering from melasma Epidermal the face of mild and moderate;

• Patients who have not done any treatment for melasma in the 3 months preceding the study;

• Patients with good mental and physical health;

• Patients who agree with the purposes of the study and sign the TCLE.

Exclusion Criteria:

• Patients with skin diseases other than melasma, which interfere in clinical evaluation as hemangiomas and queloides;

• Patients with melasma skin or mixed;

• Patients with sensitivity to agents hipopigmentantes;

• Patients with sensitivity to fotoprotetores;

• Patients who are pregnant or breastfeeding;

• Patients who, at the discretion doctor, are not able to participate in the study;

• Patients who have carried out any treatment for melasma in the 3 months preceding the study

• Patients who do not agree with the terms described in the Statement of Informed Consent